Medication Trial for Social and Communication Deficits

We are looking for children and adolescents, ages 5-17, for a study involving a new medication for Autism. The aViation study will test a potential new treatment for ‘high-functioning’ autism spectrum disorder (ASD). The investigational study drug blocks a hormone receptor in the brain that is linked to the control of socialization, stress, anxiety and aggression.

Participation lasts for up to 39 weeks. For 24 of those weeks, they will take daily doses of either the investigational study drug or a placebo (a look-alike) that contains no medicine. Both the investigational study drug and the placebo are small tablets that can be swallowed whole or dissolved in liquid.

Your time will be compensated. This study is sponsored by Roche Pharmaceuticals.

If interested, please contact Matthew Maloney at 615-343-2018 or matthew.maloney@vanderbilt.edu

 

 

Write a Comment

Your email address will not be published. Required fields are marked *

Contact Us

P: (615) 385-2077
F: (615) 383-1176
T: (866) 508-4987
955 Woodland Street
Nashville, TN 37206
Office Hours: Mon-Thurs 10:00 am – 3:00 pm
(Open Late Tuesday 10:00 am - 5:00 pm)
Additional hours available by appointment.

Newsletter

Don’t be shy! Sign up to receive our email newsletter and stay connected to what is going on in the Middle Tennessee autism community.

Facebook